Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Status:
COMPLETED
Trial end date:
2025-06-12
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the safety and tolerability of single doses of TV-44749 for subcutaneous (sc) use in Chinese participants with schizophrenia.
Secondary Objectives:
* To evaluate the pharmacokinetics (PK) of single doses of TV-44749 administered sc.
* To evaluate the pharmacokinetics of oral olanzapine tablets following multiple dose administration.
* To monitor the safety and tolerability of multiple doses of oral olanzapine tablets given in the study.